Caroline Baumal - Net Worth and Insider Trading

Caroline Baumal Net Worth

The estimated net worth of Caroline Baumal is at least $1 Million dollars as of 2024-05-24. Caroline Baumal is the Chief Medical Officer of Apellis Pharmaceuticals Inc and owns about 32,931 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $1 Million. Details can be seen in Caroline Baumal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caroline Baumal has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).

Transaction Summary of Caroline Baumal

To

Caroline Baumal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caroline Baumal owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of Caroline Baumal’s form 4 insider trades.

Insider Ownership Summary of Caroline Baumal

Ticker Comapny Transaction Date Type of Owner
APLS Apellis Pharmaceuticals Inc 2024-01-04 Chief Medical Officer

Caroline Baumal Latest Holdings Summary

Caroline Baumal currently owns a total of 1 stock. Caroline Baumal owns 32,931 shares of Apellis Pharmaceuticals Inc (APLS) as of January 4, 2024, with a value of $1 Million.

Latest Holdings of Caroline Baumal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APLS Apellis Pharmaceuticals Inc 2024-01-04 32,931 39.68 1,306,702

Holding Weightings of Caroline Baumal


Caroline Baumal Form 4 Trading Tracker

According to the SEC Form 4 filings, Caroline Baumal has made a total of 1 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 2,751 shares on January 4, 2024, which brought Caroline Baumal around $165,198.

Insider Trading History of Caroline Baumal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caroline Baumal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Caroline Baumal Ownership Network

Ownership Network List of Caroline Baumal

No Data

Ownership Network Relation of Caroline Baumal


Caroline Baumal Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Caroline Baumal is the Chief Medical Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include Chief Operating Officer Pascal Deschatelets , Chief Financial Officer Timothy Eugene Sullivan , and Senior Vice President Mark Jeffrey Delong .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Caroline Baumal made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 368,688 shares made by Pascal Deschatelets , a net sale of 15,000 shares made by Alec Machiels , and a net sale of 551,287 shares made by Cedric Francois .

In summary, during the past 3 months, insiders sold 511,119 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 511,119 shares. During the past 18 months, 1,409,109 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,409,109 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Caroline Baumal Mailing Address

Above is the net worth, insider trading, and ownership report for Caroline Baumal. You might contact Caroline Baumal via mailing address: C/o Apellis Pharmaceuticals, Inc., 100 5th Avenue, 3rd Floor, Waltham Ma 02451.

Discussions on Caroline Baumal

No discussions yet.